Sort
30,917 grants matching “tumor microenvironment”
Molecular, Cellular, and Tissue Characterization Unit
$996,148William E Gillanders · Washington University · U2C · FY2018 · CA
Role of the microbiota in regulating the mononuclear phagocyte system
$996,061Silvana Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Modeling HIV CAR-T cell trafficking and persistence in Non-Human Primates
$996,038Hans-Peter Kiem · University Of Pennsylvania · U19 · FY2020 · AI
Reprogramming of T cells for the Treatment of Melanoma
$995,664Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Reprogramming of T cells for the Treatment of Melanoma
$995,664Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Reprogramming of T cells for the Treatment of Melanoma
$995,664Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$994,901Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA
Reprogramming the Tumor-Immune Interface in Oral Cancer
$994,309John B Sunwoo · Stanford University · R35 · FY2023 · DE
A novel immuno-oncolytic viral therapy for the treatment of non-small cell lung carcinoma
$994,294Stephen H Thorne · Western Oncolytics, Ltd · R44 · FY2020 · CA
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$993,003Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
$992,724Dashtimoghadam Erfan · Symphony Biosciences, Inc. · R44 · FY2024 · CA
Molecular, Cellular, and Tissue Characterization Unit
$992,570William E Gillanders · Washington University · U2C · FY2020 · CA
Human natural killer cells: Advancing biology and clinical applications
$992,214Michael A Caligiuri · Beckman Research Institute/City Of Hope · R35 · FY2018 · CA
AGING AS A SELECTIVE PRESSURE THAT DRIVES TUMOR PROGRESSION
$990,450Ana Da Silva Gomes · H. Lee Moffitt Cancer Ctr & Res Inst · DP2 · FY2024 · AG
Biostatistics Core Resource
$990,067Susan G. Groshen · University Of Southern California · P30 · FY2010 · CA
Understanding Hemotopoietic Neoplasias using Humanized Mice
$990,065Richard A Flavell · Yale University · R01 · FY2012 · CA
Dissecting the enhancer logic governing immune cell fate decisions
$990,000Debattama Rai Sen · Massachusetts General Hospital · DP2 · FY2025 · AI
Probing functioning lung at the cellular resolution in health and disease
$990,000Hadi Tavakoli Nia · Boston University (Charles River Campus) · DP2 · FY2025 · HL
Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer
$989,826Eliseu O. De Oliveira · Coare Holdings, Inc. · R44 · FY2021 · CA
The power of extracellular vesicles in glioblastoma
$989,400Xandra Owens Breakefield · Massachusetts General Hospital · R35 · FY2022 · CA
The power of extracellular vesicles in glioblastoma
$989,360Xandra Owens Breakefield · Massachusetts General Hospital · R35 · FY2023 · CA
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
$989,275Scarlett L Gomez · University Of California, San Francisco · R01 · FY2024 · CA
Molecular, Cellular, and Tissue Characterization Unit
$988,750William E Gillanders · Washington University · U2C · FY2021 · CA
Roles of tumor suppressors (TSs) in metastatic progression
$988,119Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
$987,911Dashtimoghadam Erfan · Symphony Biosciences, Inc. · R44 · FY2025 · CA